GlassScriptPhysician profile
Daniel M Ahn
NPI 1730683400
$8,430.58
in general payments reported to CMS, 2019-2025
12 companies · $7,122 in 2025
The $7,122 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $39.91 · 2022: $44.13 · 2023: $372 · 2024: $852 · 2025: $7,122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $6,472 · Food and Beverage: $1,874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $6,472.22 |
| Food and Beverage | $1,874.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $6,472.22 | 2025 | Auryon Laser System 100-120 Vac |
| Tactile Systems Technology INC | $1,383.46 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Sun Pharmaceutical Industries INC. | $184.64 | 2023-2024 | Cequa |
| Medtronic, INC. | $162.38 | 2025 | Venaseal |
| Bausch & Lomb Americas INC. | $57.78 | 2024-2025 | Miebo, Xiidra |
| Amgen INC. | $39.91 | 2021 | |
| Inari Medical, INC. | $37.26 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Dompe US, INC. | $30.29 | 2025 | Oxervate |
| Novo Nordisk INC | $29.87 | 2022 | |
| Glaukos Corporation | $18.51 | 2025 | Istent |
| Lilly USA, LLC | $14.26 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Ahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.